Termination of translation in eukaryotes is governed by two interacting polypeptide chain release factors, eRF1 and eRF3. G Zhouravleva, L Frolova, X Le Goff, R Le Guellec, S Inge‐Vechtomov, ... The EMBO journal 14 (16), 4065-4072, 1995 | 793 | 1995 |
Eukaryotic polypeptide chain release factor eRF3 is an eRF1-and ribosome-dependent guanosine triphosphatase. L Frolova, X Le Goff, G Zhouravleva, E Davydova, M Philippe, L Kisselev Rna 2 (4), 334, 1996 | 344 | 1996 |
Poly (A)-binding protein acts in translation termination via eukaryotic release factor 3 interaction and does not influence [PSI+] propagation B Cosson, A Couturier, S Chabelskaya, D Kiktev, S Inge-Vechtomov, ... Molecular and cellular biology, 2002 | 200 | 2002 |
Eukaryotic release factors (eRFs) history S Inge‐Vechtomov, G Zhouravleva, M Philippe Biology of the Cell 95 (3‐4), 195-209, 2003 | 177 | 2003 |
Poly(A)‐binding protein and eRF3 are associated in vivo in human and Xenopus cells B Cosson, N Berkova, A Couturier, S Chabelskaya, M Philippe, ... Biology of the Cell 94 (4‐5), 205-216, 2002 | 86 | 2002 |
Viable nonsense mutants for the essential gene SUP45 of Saccharomyces cerevisiae SE Moskalenko, SV Chabelskaya, SG Inge-Vechtomov, M Philippe, ... BMC Molecular Biology 4, 1-14, 2003 | 80 | 2003 |
Nonsense mutations in the essential gene SUP35 of Saccharomyces cerevisiae are non-lethal S Chabelskaya, D Kiktev, S Inge-Vechtomov, M Philippe, G Zhouravleva Molecular Genetics and Genomics 272, 297-307, 2004 | 67 | 2004 |
The product of the mammalian orthologue of the Saccharomyces cerevisiae HBS1 gene is phylogenetically related to eukaryotic release factor 3 (eRF3) but does … C Wallrapp, SB Verrier, G Zhouravleva, H Philippe, M Philippe, TM Gress, ... FEBS letters 440 (3), 387-392, 1998 | 60 | 1998 |
Characterization of the poly(A) binding proteins expressed during oogenesis and early development of Xenopus laevis B Cosson, A Couturier, R Le Guellec, J Moreau, S Chabelskaya, ... Biology of the Cell 94 (4‐5), 217-231, 2002 | 50 | 2002 |
Protein co-aggregation related to amyloids: methods of investigation, diversity, and classification SA Bondarev, KS Antonets, AV Kajava, AA Nizhnikov, GA Zhouravleva International journal of molecular sciences 19 (8), 2292, 2018 | 48 | 2018 |
Механизмы множественной устойчивости бактерий к антибиотикам ОМ Землянко, ТМ Рогоза, ГА Журавлева Экологическая генетика 16 (3), 4-17, 2018 | 45 | 2018 |
Biological roles of prion domains S Inge-Vechtomov, G Zhouravleva, YO Chernoff Prion 1 (4), 228-235, 2007 | 43 | 2007 |
Mouse GSPT2, but not GSPT1, can substitute for yeast eRF3 in vivo C Le Goff, O Zemlyanko, S Moskalenko, N Berkova, S Inge‐Vechtomov, ... Genes to Cells 7 (10), 1043-1057, 2002 | 38 | 2002 |
Differential effects of chaperones on yeast prions: CURrent view AG Matveenko, YA Barbitoff, LM Jay-Garcia, YO Chernoff, ... Current genetics 64, 317-325, 2018 | 37 | 2018 |
Amyloid and amyloid-like aggregates: Diversity and the term crisis AB Matiiv, NP Trubitsina, AG Matveenko, YA Barbitoff, GA Zhouravleva, ... Biochemistry (Moscow) 85, 1011-1034, 2020 | 34 | 2020 |
To CURe or not to CURe? Differential effects of the chaperone sorting factor Cur1 on yeast prions are mediated by the chaperone Sis1 YA Barbitoff, AG Matveenko, SE Moskalenko, OM Zemlyanko, ... Molecular Microbiology 105 (2), 242-257, 2017 | 33 | 2017 |
Effect of charged residues in the N-domain of Sup35 protein on prion [PSI+] stability and propagation SA Bondarev, VV Shchepachev, AV Kajava, GA Zhouravleva Journal of Biological Chemistry 288 (40), 28503-28513, 2013 | 33 | 2013 |
Stoichiometry and affinity of thioflavin T binding to Sup35p amyloid fibrils AI Sulatskaya, IM Kuznetsova, MV Belousov, SA Bondarev, ... PloS one 11 (5), e0156314, 2016 | 30 | 2016 |
The paradox of viable sup45 STOP mutations: a necessary equilibrium between translational readthrough, activity and stability of the protein D Kiktev, S Moskalenko, O Murina, A Baudin-Baillieu, JP Rousset, ... Molecular genetics and genomics 282, 83-96, 2009 | 29 | 2009 |
SFP1‐mediated prion‐dependent lethality is caused by increased Sup35 aggregation and alleviated by Sis1 AG Matveenko, PB Drozdova, MV Belousov, SE Moskalenko, ... Genes to Cells 21 (12), 1290-1308, 2016 | 25 | 2016 |